Bioness Inc. L300 Foot Drop System Progressively Improves Walking Speed In Stroke Survivors

VALENCIA, Calif.--(BUSINESS WIRE)--Bioness, Inc. today announced positive results from the Company’s 42-week Functional Ambulation: Standard Treatment vs. Electrical Stimulation Therapy (FASTEST) trial of the Bioness L300® Foot Drop System. The results have been published in the July issue of PM&R. The study, titled “Response and Prediction of Improvement in Gait Speed from Functional Electrical Stimulation in Post-Stroke Drop Foot,” demonstrated that persons with drop foot following stroke had clinically meaningful and statistically significant improvement in gait speed when using the Bioness L300.

“The long-term consequences of stroke, including limitations in mobility and walking, can be particularly isolating for patients. Often stroke survivors become dependent on others to complete self care and get around in the house and, especially, the community,” said Michael W. O’Dell, M.D., chief of clinical rehabilitation services, New York-Presbyterian/Weill Cornell Medical Center, and lead author on the paper. “This study demonstrates that subjects with chronic stroke can achieve a meaningful improvement in the speed of their ambulation with functional electrical stimulation therapy. Moreover, at 42 weeks the subjects in this study walked faster with and without the device, indicating a therapeutic effect that can be sustained over time.”

Help employers find you! Check out all the jobs and post your resume.